AAM
REGN icon

Ardevora Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Ardevora Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-67,614
Closed -$48.6M – 128
2023
Q2 		$48.6M Sell
67,614
-27,114
-29% -$20.9M 1.18% 28
2023
Q1 		$77.8M Buy
94,728
+2,595
+3% +$1.96M 1.4% 22
2022
Q4 		$66.5M Buy
+92,133
New +$68M 1.13% 30
2018
Q2 		– Sell
-78,300
Closed -$27M – 129
2018
Q1 		$27M Buy
78,300
+600
+0.8% +$209K 0.8% 84
2017
Q4 		$29.2M Buy
77,700
+21,600
+39% +$8.75M 0.88% 77
2017
Q3 		$25.1M Buy
+56,100
New +$26.7M 0.75% 97
2016
Q1 		– Sell
-39,100
Closed -$21.2M – 102
2015
Q4 		$21.2M Buy
39,100
+19,500
+99% +$10.6M 1.4% 23
2015
Q3 		$9.12M Buy
19,600
+3,700
+23% +$1.99M 1.32% 38
2015
Q2 		$8.11M Sell
15,900
-1,300
-8% -$634K 1.41% 12
2015
Q1 		$7.76M Sell
17,200
-4,000
-19% -$1.7M 1.47% 31
2014
Q4 		$8.7M Buy
+21,200
New +$8.34M 1.89% 9

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ardevora Asset Management's REGN Position: Q3 2023 in Review

Ardevora Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 67,614 shares — an estimated $48.6M sold.

Ardevora Asset Management first reported a position in REGN in Q4 2014 and held it in 11 quarters. The position peaked at $77.8M in Q1 2023. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Ardevora Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Ardevora Asset Management sold 67,614 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $48.6M.
  • Ardevora Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 11 quarters.
  • Ardevora Asset Management's Regeneron Pharmaceuticals position peaked at $77.8M in Q1 2023.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Ardevora Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.